IL16 and immune system disorder: CTLA4, a negative regulator in auto-immune diseases, participates in the pathways of CAMs and T cell receptor signalling contributing to autoimmune tissue destruction and it might exert a down-regulatory effect on TNF-α, TGF-β, IL1-β and IL16 production.